Home Bratislava Medical Journal 2020 Bratislava Medical Journal Vol.121, No.3, p.175–181,2020

Journal info


Published Monthly, in English
Founded: 1919
ISSN 0006-9248
(E)ISSN 1336-0345

Impact factor 1.564


Aims and Scope
Editorial Info
Submission Guidelines

Select Journal

Webshop Cart

Your Cart is currently empty.

Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.

Bratislava Medical Journal Vol.121, No.3, p.175–181,2020

Title: Bacillus anthracis as a biological warfare agent: infection, diagnosis and countermeasures
Author: M. Pohanka

Abstract: AIM: Bacillus anthracis is a causative agent of zoonotic anthrax disease. In the last years, significant progress in therapy and diagnosis of anthrax was made. Concurrently, knowledge about anthrax progression, molecular pathology and release of anthrax toxin during the disease has improved. This review covers the recent progress in this field.
METHODS: In this review, specifications of B. anthracis, anthrax disease, medical and biomedical countermeasures and diagnostic tools were surveyed. The actual literature was summarized and relevance of the microorganism as a biological warfare agent and the ways how to reduce its impact including therapeutic protocols were written and discussed.
RESULTS: Currently, the microorganism is considered one of the top biological warfare agents due to lethality, long term stability of spores, easy dissemination and production. The recent research is focused on countermeasures suitable for reduction of consequences by a misuse of the microorganism in form of biological weapon (Tab. 3, Fig. 1, Ref. 101). Text in PDF www.elis.sk.

Keywords: anthrax, bacillus anthracis, biological warfare agent, biological weapon, detection, diagnosis, infection, therapy
Published online: 26-Feb-2020
Year: 2020, Volume: 121, Issue: 3 Page From: 175, Page To: 181

download file

© AEPress s.r.o
Copyright notice: For any permission to reproduce, archive or otherwise use the documents in the ELiS, please contact AEP.